eMudhra net profit rises 28% in Q1FY27, led by enterprise solutions

2 min read     Updated on 29 Jul 2026, 08:09 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

eMudhra Limited reported a consolidated net profit of ₹320 million for Q1FY27, up 27.9% YoY, with revenue rising 29.5% to ₹1,907 million. Growth was led by Enterprise Solutions, particularly in international markets, while Trust Services saw a slight decline due to temporary token supply issues. The company highlighted strategic expansions in the UAE and Kazakhstan, along with new product launches like PrivaTrust to address India's DPDP Act requirements.

powered bylight_fuzz_icon
46880793

*this image is generated using AI for illustrative purposes only.

eMudhra Limited reported a consolidated net profit of ₹320 million for the quarter ended June 30, 2026, marking a 27.9% increase from ₹250 million in the corresponding period of FY26. Consolidated revenue from operations rose 29.5% year-on-year to ₹1,907 million, driven by robust growth in its international Enterprise Solutions business. The strong top-line expansion translated into improved profitability, with EBITDA reaching ₹504 million and operating profit hitting ₹393.69 million.

The Board of Directors approved the unaudited standalone and consolidated financial statements at a meeting held on July 29, 2026. The results were reviewed by the statutory auditor, Suri & Co., pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The financial statements were prepared in accordance with Indian Accounting Standards (Ind AS).

Consolidated Financial Performance

Consolidated income from operations stood at ₹1,907 million, compared to ₹1,472.99 million in Q1FY25. Other income decreased to ₹17.43 million from ₹33.21 million in the prior year quarter. Total expenses were ₹1,542.85 million, an increase from ₹1,195.48 million in Q1FY25, primarily due to higher employee benefits expense of ₹386.50 million and depreciation and amortisation of ₹119.78 million.

Particulars Q1FY27 (₹ Mn) Q1FY26 (₹ Mn) Change (%)
Revenue from Operations 1,907.15 1,472.99 29.5%
EBITDA 504 359 40.4%
Operating Profit 393.69 312.73 25.9%
Net Profit 319.97 250.24 27.9%
Earnings Per Share (Basic) ₹3.91 ₹3.05 28.2%

Standalone net profit rose sharply to ₹124.19 million from ₹58.26 million in Q1FY26, a 113.2% year-on-year increase. Standalone revenue grew 19.1% to ₹661.13 million.

Segment-wise Breakdown

The Enterprise Solutions segment contributed significantly to the revenue growth, accounting for approximately 65% of total revenue. External sales from Enterprise Solutions outside India surged 35.4% to ₹1,254.64 million from ₹926.54 million in Q1FY25. Trust Services revenue declined slightly to ₹284.15 million from ₹291.77 million, reflecting a temporary supply-chain gap for retail tokens following a CCA-mandated shift to a higher security standard. Services revenue accounted for approximately 20% of total revenue, growing approximately 5% year-on-year.

What the Numbers Show

The disproportionate rise in standalone net profit (113.2%) compared to consolidated net profit (27.9%) indicates that the holding company’s operational efficiency or cost structure improved significantly more than its subsidiaries during the quarter. While consolidated revenue grew nearly 30%, the enterprise solutions segment outside India accounted for the bulk of this expansion, suggesting continued international demand for digital trust services. Conversely, the Trust Services segment saw a marginal decline in external sales, highlighting a shift in revenue mix towards higher-growth international enterprise contracts.

Strategic Developments and Outlook

V. Srinivasan, Executive Chairman, noted that the company began FY27 with good growth in Enterprise Solutions, powered by product-led growth across international markets. In Europe, the Cryptas platform is driving synergies for emSigner and Certinext. The company expects to launch Trust Services in the UAE in Q2/Q3 FY27, providing an opening to sell eSign offerings in that market. Additionally, advanced conversations are underway with large regulated public sector and defense entities in Kazakhstan.

In India, the Trust Services business saw a temporary impact due to the token supply-chain gap, which management expects to normalize from Q3FY27. The eSign business continued steady penetration across new and existing customer segments. The Digital Personal Data Protection (DPDP) Act is adding relevance to the company’s products, with the Consent Manager framework due to become operational in November 2026 and full substantive compliance required by May 2027. This timeline validates the development of PrivaTrust, the company’s data-privacy platform.

Historical Stock Returns for eMudhra

1 Day5 Days1 Month6 Months1 Year5 Years
-1.24%-1.76%+2.67%-13.28%-43.78%+76.19%

How will the upcoming operationalization of the Consent Manager framework under the DPDP Act in November 2026 impact eMudhra's adoption rates for its PrivaTrust platform?

What specific revenue synergies are expected from the integration of the Cryptas platform with emSigner and Certinext in European markets during FY27?

Could you elaborate on the timeline and potential revenue contribution from the advanced discussions with regulated public sector and defense entities in Kazakhstan?

eMudhra Ltd Schedules Analyst and Institutional Investor Meeting on August 03, 2026

1 min read     Updated on 29 Jul 2026, 06:21 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

eMudhra Limited has announced a group analyst and institutional investor meeting scheduled for Monday, August 03, 2026, at 08:30 AM IST in Mumbai, Maharashtra. The meeting will include Nippon MF, Pinebridge, UTI MF, and Bandhan MF. The disclosure was filed on July 29, 2026, by Company Secretary & Compliance Officer Johnson Xavier, pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has noted that the schedule and participants are subject to change.

powered bylight_fuzz_icon
46875070

*this image is generated using AI for illustrative purposes only.

eMudhra Limited has notified the stock exchanges of a scheduled group meeting with institutional investors and analysts, to be held on Monday, August 03, 2026, at 08:30 AM IST in Mumbai, Maharashtra. The disclosure was made in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and was communicated via an official filing dated July 29, 2026, signed by Company Secretary & Compliance Officer Johnson Xavier.

Meeting Details

The upcoming analyst and institutional investor meeting brings together representatives from four prominent financial institutions. The following table outlines the key details of the scheduled interaction:

Parameter: Details
Date: Monday, August 03, 2026
Time: 08:30 AM IST
Type: Group Meeting
Location: Mumbai, Maharashtra
Participants: Nippon MF, Pinebridge, UTI MF, Bandhan MF

Participating Institutions

The group meeting is scheduled to include the following institutional investors and analysts:

  • Nippon MF
  • Pinebridge
  • UTI MF
  • Bandhan MF

Regulatory Compliance

The filing was submitted to both BSE Limited and the National Stock Exchange of India Limited in accordance with applicable listing regulations. eMudhra has noted that the schedule and participants mentioned are subject to change, which may occur due to exigencies on the part of the analyst, investor, or the company.

Historical Stock Returns for eMudhra

1 Day5 Days1 Month6 Months1 Year5 Years
-1.24%-1.76%+2.67%-13.28%-43.78%+76.19%

What specific strategic updates or financial guidance is eMudhra likely to present to these institutional investors during the August 3 meeting?

How might the participation of major mutual funds like Nippon and UTI influence eMudhra's stock liquidity and valuation in the near term?

Are there any pending regulatory changes in India's digital signature or cybersecurity sectors that could impact eMudhra's future revenue streams?

More News on eMudhra

1 Year Returns:-43.78%